Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001127602-20-002078
Filing Date
2020-01-21
Accepted
2020-01-21 16:02:52
Documents
1
Period of Report
2018-11-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4a.html 4/A  
1 PRIMARY DOCUMENT form4a.xml 4/A 7129
  Complete submission text file 0001127602-20-002078.txt   8527
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

EIN.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
SULLIVAN LOUIS W (Reporting) CIK: 0001193522 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-26301 | Film No.: 20536441